NVIDIA launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference last week, and deals with Johnson & Johnson and GE Healthcare for surgery and medical imaging.
"The reason why Nvidia is so popular today is because it basically provided the plumbing and the technology for something that you could not do simply before or if you had to do something like this you would need probably several times more time, money and cost," said Raj Joshi, a technology analyst and senior vice president at Moody's Ratings. "Health care, whether it's biotechnology, chemicals, or drug discovery is a very powerful area.
Drug development is a risky process that can take at least a decade from concept to clinical studies, Ural said. It's also a process that can cost billions, with a high chance of failure. "In healthcare, digital biology and generative AI are helping to reinvent drug discovery, surgery, medical imaging and wearable devices," said Colette Kress, Nvidia chief financial officer. "We have built deep domain expertise in healthcare over the past decade, creating the NVIDIA Clara healthcare platform and NVIDIA BioNeMo, a generative AI service to develop, customize and deploy AI foundation models for computer-aided drug discovery."for its drug discovery projects.
Ai Ai Latest News, Ai Ai Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: DigitalTrends - 🏆 95. / 65 Read more »